BACKGROUND: Advanced esophageal adenocarcinomas are associated with 5-year
survival rates ranging from 14% to 35%. Nodal status and tumor clearance are the main …

Background Knowledge of factors related to outcome is vital for the selection of therapeutic
alternatives for patients with early (T1) esophageal adenocarcinoma. This study was …

Background Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced
esophageal adenocarcinomas (EAC). Pathological response is thought to be a major …

Objective Using a population-based registry, we evaluated the impact of neoadjuvant
radiotherapy and lymphadenectomy on survival of patients undergoing curative-intent …

Background In the UK, it is standard practice to treat esophageal adenocarcinoma with
neoadjuvant chemotherapy (no radiation) and surgery. We examined the prognostic value of …

Objective The current staging system for esophageal adenocarcinoma only considers tumor
grade in early tumors. The aim of this study was to evaluate the impact of tumor …

Objective: To compare overall survival in patients with esophageal adenocarcinoma who
underwent transhiatal esophagectomy (THE) with limited lymphadenectomy or transthoracic …

Barely 50 years ago, the very existence of a primary adenocarcinoma of the esophagus was
debated, and this rare tumor was a novelty in comparison with squamous cell esophageal …

Background. The depth of tumor invasion (T) and regional lymph node status (N) are two
factors that define the stage of an esophageal carcinoma. However, the arrangement of …

Background. The main purpose of this study was to determine prognostic factors in patients
with surgical treatment of adenocarcinoma of the esophagus. Methods. Within a 12.5-year …